Spiriva respimat and Ursodiol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 21 people who take Spiriva respimat and Ursodiol. Common interactions include hypoaesthesia among females, and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Spiriva respimat and Ursodiol have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 24, 2023

21 people who take Spiriva respimat and Ursodiol together, and have interactions are studied.


What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is used in chronic obstructive pulmonary disease. Currently, eHealthMe is studying from 8,577 Spiriva respimat users.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is used in primary biliary cirrhosis. Currently, eHealthMe is studying from 16,848 Ursodiol users.

Number of Spiriva respimat and Ursodiol reports submitted per year:

Spiriva respimat and Ursodiol drug interactions.

Common Spiriva Respimat and Ursodiol drug interactions by gender *:

female:

  1. Hypoaesthesia
  2. Hypogammaglobulinaemia
  3. Hypothyroidism
  4. Immunosuppression
  5. Infection susceptibility increased
  6. Intra-abdominal haematoma
  7. Marrow hyperplasia
  8. Mental impairment
  9. Oxygen saturation decreased
  10. Paraesthesia

male:

  1. Dyspnoea
  2. Back pain
  3. Anal abscess
  4. Angiopathy
  5. Anxiety
  6. Arrhythmia
  7. Asthenia
  8. Back disorder
  9. Blood urine present
  10. Bronchitis


Common Spiriva Respimat and Ursodiol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Headache
  2. Influenza
  3. Insomnia
  4. Intestinal obstruction
  5. Joint swelling
  6. Nausea
  7. Pain
  8. Pain in extremity
  9. Panic attack
  10. Peripheral swelling

40-49:

n/a

50-59:

  1. Hypertension
  2. Hypoaesthesia
  3. Paraesthesia
  4. Abdominal discomfort
  5. Abdominal pain
  6. Angiopathy
  7. Anxiety
  8. Arrhythmia
  9. Asthenia
  10. Back disorder

60+:

  1. Anal abscess
  2. Decreased appetite
  3. Dyspnoea
  4. Hyponatraemia
  5. Fluid retention
  6. Localised oedema
  7. Oedema
  8. Pneumonia
  9. Surgery

Common conditions people have *:

  1. Cystic Fibrosis (disease of the secretary glands): 5 people, 23.81%
  2. Gastric Ulcer (stomach ulcer): 4 people, 19.05%
  3. Asthma: 3 people, 14.29%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
  5. Hepatocellular Carcinoma (liver cancer): 2 people, 9.52%
  6. Hepatitis B: 2 people, 9.52%
  7. Fever: 2 people, 9.52%
  8. Constipation: 2 people, 9.52%
  9. Back Pain: 2 people, 9.52%
  10. Ascites (accumulation of fluid in the abdominal cavity): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva respimat and Ursodiol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Drug side effects by duration, gender and age:

Common Spiriva respimat drug interactions:

Browse interactions between Spiriva respimat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ursodiol drug interactions:

Browse interactions between Ursodiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide and ursodiol (the active ingredients of Spiriva respimat and Ursodiol, respectively), and Spiriva respimat and Ursodiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Spiriva respimat and Ursodiol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: